Abstract |
We used a combined approach based on fragment-based drug design (FBDD) and in silico methods to design potential inhibitors of the cytosolic 5'-nucleotidase II (cN-II), which has been recognized as an important therapeutic target in hematological cancers. Two subgroups of small compounds (including adenine and biaryl moieties) were identified as cN-II binders and a fragment growing strategy guided by molecular docking was considered. Five compounds induced a strong inhibition of the 5'-nucleotidase activity in vitro, and the most potent ones were characterized as noncompetitive inhibitors. Biological evaluation in cancer cell lines showed synergic effect with selected anticancer drugs. Structural studies using X-ray crystallography lead to the identification of new binding sites for two derivatives and of a new crystal form showing important domain swapping. Altogether, the strategy developed herein allowed identifying new original noncompetitive inhibitors against cN-II that act in a synergistic manner with well-known antitumoral agents.
|
Authors | Zsuzsanna Marton, Rémi Guillon, Isabelle Krimm, Preeti, Rahila Rahimova, David Egron, Lars P Jordheim, Nushin Aghajari, Charles Dumontet, Christian Périgaud, Corinne Lionne, Suzanne Peyrottes, Laurent Chaloin |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 58
Issue 24
Pg. 9680-96
(Dec 24 2015)
ISSN: 1520-4804 [Electronic] United States |
PMID | 26599519
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Benzamides
- Benzoates
- Imidazoles
- Naphthalenes
- Purines
- Pyrroles
- 5'-Nucleotidase
- NT5C2 protein, human
|
Topics |
- 5'-Nucleotidase
(antagonists & inhibitors)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Benzamides
(chemical synthesis, chemistry, pharmacology)
- Benzoates
(chemical synthesis, chemistry, pharmacology)
- Binding Sites
- Cell Line, Tumor
- Computer Simulation
- Databases, Chemical
- Drug Screening Assays, Antitumor
- Drug Synergism
- Humans
- Imidazoles
(chemical synthesis, chemistry, pharmacology)
- Molecular Docking Simulation
- Naphthalenes
(chemical synthesis, chemistry, pharmacology)
- Purines
(chemical synthesis, chemistry, pharmacology)
- Pyrroles
(chemical synthesis, chemistry, pharmacology)
- Structure-Activity Relationship
|